TerminatedEarly Phase 1NCT03100123

AntiPhospholipid Syndrome Low-molecular-weight Heparin Pregnancy Loss Evaluation: The Pilot Study

Studying Antiphospholipid syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Ottawa Hospital Research Institute
Principal Investigator
Marc Rodger, MD
Ottawa Hospital Research Institute
Intervention
Aspirin 81 mg(drug)
Enrollment
1 enrolled
Eligibility
18 years · FEMALE
Timeline
2017 – 2019

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03100123 on ClinicalTrials.gov

Other trials for Antiphospholipid syndrome

Additional recruiting or active studies for the same condition.

See all trials for Antiphospholipid syndrome →

← Back to all trials